- News and Events
- Ferguson Support
- Perspectives on Fighting Human Trafficking
- Clinics 40th
- PILG Auction 2014
- Law Student Symposium 2014
- PDP Alumni Appreciation Night
- Scott Hall Inaugural Year Events
- James C. Millstone Memorial Lecture 2013
- James C. Millstone Memorial Lecture 2015
- Court Week
- Health Law Symposia
- Health Law Symposium 2014
- Health Law Symposium 2013
- Health Reform 2012
- Health Law Symposium 2012
- Health Law Symposium 2011
- Public Law Review Symposia
- Richard J. Childress Memorial Lecture
- SLU Zone Third Thursday Promotions
- Scholarship Day
- Vincent C. Immel Lecture
- Dining, Lodging, and Travel
- US Labor Law: A Political Battlefield
- Past Events
- Scott Hall Information
- Submit a news item
- Videos and Podcasts
- Contact Communications
Speakers and Journal Authors
Kathleen M. Boozang
Professor Kathleen Boozang is currently serving as the Interim Vice Provost of Seton Hall University in South Orange, New Jersey. In that capacity, she works closely with the Provost as well as the school and college deans administering the university’s academic programs. Prior to moving to the university’s main campus, Professor Boozang served for eight years as the Law School’s Associate Dean, and then for two years as the Associate Dean for Academic Advancement, with oversight of two of the Law School’s Centers of Excellence: the Gibbons Institute of Law Science and Technology, and the Center for Health & Pharmaceutical Law & Policy.
In her scholarship, Professor Boozang has dedicated much of her career to nonprofit governance issues with a special focus on religiously sponsored hospitals. In the last several years, however, she has expanded her research and teaching to explore the legal and policy issues related to the global pharmaceutical and medtech industries, many of which make New Jersey their headquarters.
In addition to her teaching and administrative duties, Professor Boozang serves on the Board of Directors of the American Health Lawyers Association. She is a Fellow to The Hastings Center, an independent nonprofit bioethics research institute, as well as a Fellow to the American Bar Foundation , an honorary organization of legal practitioners. She is also a member of the American Law Institute and participates on the consultant group for the Principles of Nonprofit Law. She serves on the Editorial Board of the Journal of Health and Life Sciences Law and is a past editor-in-chief of the Journal of Law, Medicine & Ethics. She is past president of the American Society of Law, Medicine & Ethics and also previously sat on the Advisory Board of the Journal of Health Law.
Throughout her legal career, Professor Boozang has been active in public service. She has served on numerous advisory boards and committees for healthcare providers and for the states of New Jersey and New York, including serving as an advisor to the New Jersey Attorney General Task Force on Physician Compensation by Pharmaceutical Companies, which resulted in the promulgation of proposed regulation. She is currently a member of the New York State Task Force on Life and the Law, an interdisciplinary commission with a mandate to develop public policy on bioethical issues.
Professor Boozang was named the Seton Hall University Woman of the Year in 2006 and the Washington University Law School’s Young Alum of the Year in 2004. She graduated from Washington University School of Law in St. Louis, Mo., where she was inducted into the Order of the Coif and served as the managing editor of Law Quarterly. She received her LL.M. from Yale Law School in 1990.
Robert I. Field
Robert I. Field holds a joint appointment as professor of law at the Earle Mack School of Law and professor of health management and policy at the School of Public Health at Drexel University. He is also a lecturer in health care management at the Wharton School of the University of Pennsylvania and an adjunct senior fellow of Penn’s Leonard Davis Institute of Health Economics. He is the author of Health Care Regulation in America: Complexity, Confrontation and Compromise, a comprehensive overview of the government’s oversight of health care published by Oxford University Press. Prof. Field is frequently interviewed by local and national media outlets on issues related to health law and health policy. He writes a regular blog focusing on health policy for the Philadelphia Inquirer. He has a Ph.D. in psychology from Boston University, M.P.H. from the Harvard School of Public Health, J.D. from Columbia Law School where he was associate editor of the Columbia Journal of Environmental Law, and A.B. magna cum laude from Harvard College.
Marc A. Rodwin
Marc A. Rodwin is Professor of Law at Suffolk University Law School. He is the author of Conflicts of Interest and the Future of Medicine: The United States, France and Japan (Oxford, 2011); and Medicine, Money & Morals: Physicians' Conflicts of Interest (Oxford, 1993). Rodwin has testified before Congress and state legislatures and served on government commissions and advisory boards, including the Food and Drug Administration and the Indiana Commission on Hospital Antitrust. He has participated in meetings of the National Academy of Sciences, Institute of Medicine.
Rodwin has assisted consumer groups including the Consumer Federation of America, the National Partnership for Women and Families, and Consumer Coalition for Quality Health Care. He has worked as a consultant or expert witness on policy-related litigation involving fiduciary law, physicians' conflicts of interests, competition law, and managed care in numerous lawsuits.
Rodwin has been a recipient of several fellowships and grants including: Edmond J. Safra Ethics Center Lab Fellowship; Fulbright Fellowship, German Marshal Fund, Social Science Research Council/Abe Fellowship; Robert Wood Johnson Foundation Investigator Award, and the Pew Health Policy Doctoral Fellowship.
Prior to joining Suffolk University, Rodwin was Associate Professor at Indiana University School of Public and Environmental Affairs and before that, he was a lecturer at Tufts and Brandeis Universities. He has also practiced civil litigation in Boston law firms and worked as a consultant. Member, Phi Beta Kappa.
Jeremy Sugarman, MD, MPH, MA is the Harvey M. Meyerhoff Professor of Bioethics and Medicine, professor of medicine, professor of Health Policy and Management, and deputy director for medicine of the Berman Institute of Bioethics at the Johns Hopkins University. He is an internationally recognized leader in the field of biomedical ethics with particular expertise in the application of empirical methods and evidence-based standards for the evaluation and analysis of bioethical issues. His contributions to both medical ethics and policy include his work on the ethics of informed consent, umbilical cord blood banking, stem cell research, international HIV prevention research, and research oversight.
Dr. Sugarman is the author of over 200 articles, reviews and book chapters. He has also edited or co-edited four books (Beyond Consent: Seeking Justice in Research; Ethics of Research with Human Subjects: Selected Policies and Resources; Ethics in Primary Care; and Methods in Medical Ethics). Dr. Sugarman is an associate editor of Clinical Trials, a contributing editor for IRB, and is on the editorial boards of several academic journals.
Dr. Sugarman consults and speaks internationally on a range of issues related to bioethics. He has served as senior policy and research analyst for the White House Advisory Committee on Human Radiation Experiments, consultant to the National Bioethics Advisory Commission, and Senior Adviser to the Presidential Commission for the Study of Bioethical Issues.
He was the founding director of the Trent Center for Bioethics, Humanities and History of Medicine at Duke University where he was also a professor of medicine and philosophy. He is a faculty affiliate of the Kennedy Institute of Ethics at Georgetown University.
Dr. Sugarman currently serves on the Maryland Stem Cell Research Commission, the Scientific and Research Advisory Board for the Canadian Blood Service, the Ethics and Public Policy Committee of the International Society for Stem Cell Research, and the Board of Directors of PRIM&R (Public Responsibility in Medicine and Research). He is co-chair of the Johns Hopkins’ Institutional Stem Cell Research Oversight Committee. In addition, he is chair of the Ethics Working Group of the HIV Prevention Trials Network and is the ethics officer for the Resuscitation Outcomes Consortium.
Dr. Sugarman has been elected as a member of the American Society of Clinical Investigation and the Institute of Medicine. He is a fellow of the American Association for the Advancement of Science, the American College of Physicians and the Hastings Center.